Episenta - new formulation of sodium valproate

Beacon Pharmaceuticals has launched Episenta (sodium valproate) capsules and sachets, indicated for the treatment of all forms of epilepsy.

Episenta capsules and sachets contain many minitablets, each of which is a prolonged-delivery unit, giving the option of once-a-day treatment. The minitablets can be sprinkled on to soft foods or taken with drinks.

The recommended dose for adults should start at 600mg daily increasing by 150–300mg at three-day intervals until control is achieved. This is generally within the dosage range of 1,000mg to 2,000mg per day (ie, 20–30mg/kg body weight daily). Where adequate control is not achieved within this range, the dose may be further increased to a maximum of 2,500mg per day.

Episenta solution for injection was launched earlier this year. This is a ready-to-use solution of sodium valproate (100mg/ml), in contrast to the other currently available preparation, which is available as a powder for reconstitution (95mg/mL when reconstituted due to displacement). Episenta solution for injection is available as 300mg/3ml ampoules in packs of five.

Further information: Beacon 01892 600930

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases